Johnson & Johnson buy piccolo90
Summary
This prediction ended on 13.03.17 with a price of €114.27. The BUY prediction by piccolo90 finished with a performance of 13.16%. piccolo90 has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Johnson & Johnson | 1.671% | 1.671% | -6.080% | -0.345% |
iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
Comments by piccolo90 for this prediction
In the thread Johnson & Johnson diskutieren
piccolo90 stimmt der Outperform-Einschätzung der institutionellen Analysten zu
piccolo90 stimmt am 29.11.2016 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 126.53$ zu.
Stopped prediction by piccolo90 for Johnson & Johnson
Johnson & Johnson
25.07.17
16.07.18
16.07.18